Cargando…

Tramadol versus ketorolac for pain management after third molar surgery

OBJECTIVES: To compare the analgesic efficacy of preoperative intravenous (IV) ketorolac versus tramadol in preventing postoperative pain after mandibular third molar surgery. METHODOLOGY: Two hundred patients in the age group of 18–40 years with asymptomatic impacted mandibular molars were randomly...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathi, Jugajyoti, Vidya, K. C., Sangamesh, N. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051645/
https://www.ncbi.nlm.nih.gov/pubmed/33897187
http://dx.doi.org/10.4103/njms.NJMS_78_17
_version_ 1783679772181659648
author Pathi, Jugajyoti
Vidya, K. C.
Sangamesh, N. C.
author_facet Pathi, Jugajyoti
Vidya, K. C.
Sangamesh, N. C.
author_sort Pathi, Jugajyoti
collection PubMed
description OBJECTIVES: To compare the analgesic efficacy of preoperative intravenous (IV) ketorolac versus tramadol in preventing postoperative pain after mandibular third molar surgery. METHODOLOGY: Two hundred patients in the age group of 18–40 years with asymptomatic impacted mandibular molars were randomly allocated into one of the two groups (100 in each group) and underwent third molar surgery under local anesthesia. Group I received IV ketorolac 30 mg and Group II received IV tramadol 50 mg preoperatively. The difference in postoperative pain was assessed by five primary end points: pain intensity being measured hourly by Wong-Baker pain assessment scale for 6 h, onset of analgesia, duration of action, total number of analgesics consumed, and patient's global assessment. RESULTS: Throughout the 6 h investigation period, patients reported significantly lower pain intensity scores, longer duration of action, lesser postoperative analgesic consumption, and better global assessment in ketorolac when compared to tramadol group. Patients in the ketorolac group significantly performed better than the tramadol group in terms of all parameters except onset of analgesia. All the drug-related complications were mild and did not require any investigation. CONCLUSION: The result of the present study shows that preoperative IV ketorolac 30 mg is more effective than tramadol 50 mg for postoperative pain following third molar surgery.
format Online
Article
Text
id pubmed-8051645
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80516452021-04-23 Tramadol versus ketorolac for pain management after third molar surgery Pathi, Jugajyoti Vidya, K. C. Sangamesh, N. C. Natl J Maxillofac Surg Original Article OBJECTIVES: To compare the analgesic efficacy of preoperative intravenous (IV) ketorolac versus tramadol in preventing postoperative pain after mandibular third molar surgery. METHODOLOGY: Two hundred patients in the age group of 18–40 years with asymptomatic impacted mandibular molars were randomly allocated into one of the two groups (100 in each group) and underwent third molar surgery under local anesthesia. Group I received IV ketorolac 30 mg and Group II received IV tramadol 50 mg preoperatively. The difference in postoperative pain was assessed by five primary end points: pain intensity being measured hourly by Wong-Baker pain assessment scale for 6 h, onset of analgesia, duration of action, total number of analgesics consumed, and patient's global assessment. RESULTS: Throughout the 6 h investigation period, patients reported significantly lower pain intensity scores, longer duration of action, lesser postoperative analgesic consumption, and better global assessment in ketorolac when compared to tramadol group. Patients in the ketorolac group significantly performed better than the tramadol group in terms of all parameters except onset of analgesia. All the drug-related complications were mild and did not require any investigation. CONCLUSION: The result of the present study shows that preoperative IV ketorolac 30 mg is more effective than tramadol 50 mg for postoperative pain following third molar surgery. Wolters Kluwer - Medknow 2020 2020-12-16 /pmc/articles/PMC8051645/ /pubmed/33897187 http://dx.doi.org/10.4103/njms.NJMS_78_17 Text en Copyright: © 2020 National Journal of Maxillofacial Surgery https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Pathi, Jugajyoti
Vidya, K. C.
Sangamesh, N. C.
Tramadol versus ketorolac for pain management after third molar surgery
title Tramadol versus ketorolac for pain management after third molar surgery
title_full Tramadol versus ketorolac for pain management after third molar surgery
title_fullStr Tramadol versus ketorolac for pain management after third molar surgery
title_full_unstemmed Tramadol versus ketorolac for pain management after third molar surgery
title_short Tramadol versus ketorolac for pain management after third molar surgery
title_sort tramadol versus ketorolac for pain management after third molar surgery
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051645/
https://www.ncbi.nlm.nih.gov/pubmed/33897187
http://dx.doi.org/10.4103/njms.NJMS_78_17
work_keys_str_mv AT pathijugajyoti tramadolversusketorolacforpainmanagementafterthirdmolarsurgery
AT vidyakc tramadolversusketorolacforpainmanagementafterthirdmolarsurgery
AT sangameshnc tramadolversusketorolacforpainmanagementafterthirdmolarsurgery